HeartSciences Inc. financial data

Symbol
HSCS, HSCSW on Nasdaq
Location
550 Reserve St, Suite 360, Southlake, TX
Fiscal year end
April 30
Latest financial report
10-Q - Q2 2025 - Sep 11, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 117 % -59.2%
Quick Ratio 19.2 % -38.9%
Debt-to-equity 164 % +212%
Return On Equity -383 % -166%
Return On Assets -145 % -53.8%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 2.65M shares +191%
Common Stock, Shares, Outstanding 2.28M shares +152%
Entity Public Float 5.4M USD -74.4%
Common Stock, Value, Issued 2.28K USD +151%
Weighted Average Number of Shares Outstanding, Basic 1.3M shares +67.6%
Weighted Average Number of Shares Outstanding, Diluted 1.3M shares +67.6%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 1.9K USD
Cost of Revenue 760 USD
Research and Development Expense 4.16M USD +17.5%
Operating Income (Loss) -8.15M USD -15.6%
Nonoperating Income (Expense) -618K USD -158%
Net Income (Loss) Attributable to Parent -8.77M USD -20.3%
Earnings Per Share, Basic -8 USD/shares -1.6%
Earnings Per Share, Diluted -8 USD/shares -1.6%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 2.79M USD -35.7%
Accounts Receivable, after Allowance for Credit Loss, Current 4.35K USD
Inventory, Net 650K USD +1.01%
Other Assets, Current 40.4K USD 0%
Assets, Current 4.42M USD -27.3%
Property, Plant and Equipment, Net 56.4K USD -34.5%
Operating Lease, Right-of-Use Asset 347K USD -21.2%
Assets 6.44M USD -21.4%
Accounts Payable, Current 283K USD -28.6%
Accrued Liabilities, Current 599K USD +81%
Liabilities, Current 3.01M USD +123%
Operating Lease, Liability, Noncurrent 282K USD -30.6%
Liabilities 3.3M USD +46%
Retained Earnings (Accumulated Deficit) -78.2M USD -12.6%
Stockholders' Equity Attributable to Parent 3.14M USD -47.1%
Liabilities and Equity 6.44M USD -21.4%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -1.95M USD +3.24%
Net Cash Provided by (Used in) Financing Activities 3.65M USD +561%
Net Cash Provided by (Used in) Investing Activities -814 USD +2.28%
Common Stock, Shares Authorized 500M shares 0%
Common Stock, Shares, Issued 2.28M shares +152%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 1.69M USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 2.79M USD -35.7%
Deferred Tax Assets, Valuation Allowance 15.5M USD +13.6%
Operating Lease, Liability 406K USD -20.8%
Depreciation 7.11K USD -40.1%
Lessee, Operating Lease, Liability, to be Paid 482K USD -25.2%
Property, Plant and Equipment, Gross 601K USD +0.53%
Operating Lease, Liability, Current 124K USD +16.7%
Lessee, Operating Lease, Liability, to be Paid, Year Two 174K USD +1.88%
Lessee, Operating Lease, Liability, to be Paid, Year One 169K USD +1.86%
Operating Lease, Weighted Average Discount Rate, Percent 0.12 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 75.8K USD -42.4%
Lessee, Operating Lease, Liability, to be Paid, Year Three 14.5K USD -90%
Deferred Tax Assets, Operating Loss Carryforwards 12.2M USD +4.95%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 20M shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 14.5K USD -91.7%
Operating Lease, Payments 13.1K USD 0%
Additional Paid in Capital 81.3M USD +7.93%
Interest Expense 354K USD +45.6%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%